ValenzaBio, Inc. — Form D
ValenzaBio, Inc. of BETHESDA, MD, a company, filed a Form D exempt-offering notice with the SEC on 2021-04-09. The offering totals $79.4M, of which $79.4M was reported sold. Industry: Other.
Offering
- Filed: 2021-04-09
- Form: D
- Accession: 0001855488-21-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $79.4M
- Amount sold: $79.4M
- Investors: 13
- Date of first sale: 2021-03-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-395222
Issuer
- Name: ValenzaBio, Inc.
- CIK: 0001804522
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 6701 DEMOCRACY BLVD, BETHESDA, MD, 20817
- Phone: 3017559900
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Patrick Crutcher | Director | Redwood City, CA |
| John Doux | Director | Bethesda, MD |
| David Maizenberg | Director | Bethesda, MD |
| James Silverman | Director | Bethesda, MD |
| Patrick Crutcher | Executive Officer | Redwood City, CA |
| David Maizenberg | Executive Officer | Bethesda, MD |
Other filings by this issuer (1)
More